1996
DOI: 10.1902/annals.1996.1.1.401
|View full text |Cite
|
Sign up to set email alerts
|

Periodontal Implications: Mucocutaneous Disorders

Abstract: Question SetWhat are the currently accepted treatment modalities for mucocutaneous disorders? a. Indications/contraindications for each b. Relative strengths and weaknesses for each c. Therapeutic endpoints of success for each d. Future directions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0
2

Year Published

1999
1999
2012
2012

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 192 publications
0
11
0
2
Order By: Relevance
“…Although there does not appear to be a universally successful treatment regimen for MMP, the management of oral MMP relies mostly on the use of topical corticosteroids of different concentrations. In more severe cases, systemic steroids may be used, but patients require intensive monitoring to avoid potential adverse side effects such as candidal infections, other oral infections, adrenal suppression, hypertension, diabetes mellitus, and gastric ulcers 9 . Other successful modalities presented in the literature for treatment of MMP include use of dapsone, 10,11 combinations of topical corticosteroids and dapsone, 12 intravenous immunoglobulin, 13,14 pulse intravenous cyclophosphamide, 15,16 and anti‐tumor necrosis factor‐alpha agents 17 .…”
mentioning
confidence: 99%
“…Although there does not appear to be a universally successful treatment regimen for MMP, the management of oral MMP relies mostly on the use of topical corticosteroids of different concentrations. In more severe cases, systemic steroids may be used, but patients require intensive monitoring to avoid potential adverse side effects such as candidal infections, other oral infections, adrenal suppression, hypertension, diabetes mellitus, and gastric ulcers 9 . Other successful modalities presented in the literature for treatment of MMP include use of dapsone, 10,11 combinations of topical corticosteroids and dapsone, 12 intravenous immunoglobulin, 13,14 pulse intravenous cyclophosphamide, 15,16 and anti‐tumor necrosis factor‐alpha agents 17 .…”
mentioning
confidence: 99%
“…Such histologic findings lead to a differential diagnosis of cicatricial or bullous pem-phigoid, linear IgA disease, bullous lichen planus, erythema multiforme, epidermolysis bullosa acquisita, dermatitis herpetiformis, or herpes gestationis. 6,11 As evidenced by this report, vesiculobullous conditions such as cicatricial pemphigoid do not always adhere to a typical histological presentation. Data from our Stomatology Center indicate that gingival cicatricial pemphigoid will sometimes present normal histologic features or a non-specific inflammatory response.…”
Section: Discussionmentioning
confidence: 74%
“…10,20 Review of the literature has revealed no consensus as to the proper treatment regimens for patients with oral cicatricial pemphigoid. 11 Large-scale clinical trials are lacking, with most of the published literature consisting of case reports or case series. Therefore, treatment is generally directed towards controlling the patient's symptoms, eliminating inflammation caused by plaque or prosthetic devices, and eradicating gingival and mucosal lesions.…”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…Several treatment methods have been reported (Carrozzo & Gandolfo, 1999;Chan et al, 2002;Endo et al, 2008b;Fatahzadeh et al, 2006;Kirtschig et al, 2003;Lamey et al, 1992;Motta et al, 2009;Nisengard, 1996;Nisengard & Levine, 1995). However, treatment may achieve only a temporary effect if idiopathic or autoimmune diseases are causing the DG.…”
Section: Management Of Dgmentioning
confidence: 99%